ES2155709T3 - Ensayo inmunologico para la determinacion de la avidez de inmunoglobulinas. - Google Patents

Ensayo inmunologico para la determinacion de la avidez de inmunoglobulinas.

Info

Publication number
ES2155709T3
ES2155709T3 ES98106191T ES98106191T ES2155709T3 ES 2155709 T3 ES2155709 T3 ES 2155709T3 ES 98106191 T ES98106191 T ES 98106191T ES 98106191 T ES98106191 T ES 98106191T ES 2155709 T3 ES2155709 T3 ES 2155709T3
Authority
ES
Spain
Prior art keywords
avidity
immunoglobulin
determination
diagnosis
immunological test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98106191T
Other languages
English (en)
Inventor
Wolfgang Dr Zens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg GmbH filed Critical Dade Behring Marburg GmbH
Application granted granted Critical
Publication of ES2155709T3 publication Critical patent/ES2155709T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN PROCEDIMIENTO ASI COMO A UN DIAGNOSTICO PARA LA COMPROBACION CUALITATIVA O CUANTITATIVA DE ANTICUERPOS Y PARA DETERMINAR SU AVIDIDAD MEDIANTE EL EMPLEO DE UN PEROXIDO DE UREA-HIDROGENO. POR MEDIO DE ESTO SE HACE POSIBLE EL DIAGNOSTICO DE LA FASE TEMPRANA DE INFECCIONES VIRALES, BACTERIANAS O PARASITARIAS. EL DIAGNOSTICO CONFORME A LA INVENCION ES ESPECIALMENTE APROPIADO PARA EL TRATAMIENTO AUTOMATIZADO EN GRANDES LABORATORIOS DE ANALISIS.
ES98106191T 1997-05-02 1998-04-04 Ensayo inmunologico para la determinacion de la avidez de inmunoglobulinas. Expired - Lifetime ES2155709T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19718361A DE19718361A1 (de) 1997-05-02 1997-05-02 Immunoassay zur Aviditätsbestimmung von Immunglobulinen

Publications (1)

Publication Number Publication Date
ES2155709T3 true ES2155709T3 (es) 2001-05-16

Family

ID=7828287

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98106191T Expired - Lifetime ES2155709T3 (es) 1997-05-02 1998-04-04 Ensayo inmunologico para la determinacion de la avidez de inmunoglobulinas.

Country Status (7)

Country Link
US (1) US6372426B1 (es)
EP (1) EP0875761B1 (es)
JP (1) JP3917753B2 (es)
AT (1) ATE199783T1 (es)
CA (1) CA2236554C (es)
DE (2) DE19718361A1 (es)
ES (1) ES2155709T3 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19910045A1 (de) * 1999-03-08 2000-09-14 Mikrogen Molekularbiol Entw Verfahren zur Bestimmung der Avidität von Antikörpern
WO2001044298A1 (en) * 1999-12-13 2001-06-21 Zlb Bioplasma Ag Improvement of therapeutic potential of immunoglobulin preparations
DE10232203A1 (de) * 2002-07-16 2004-02-19 Institut Virion/Serion Gmbh Verfahren und Diagnostikum zum qualitativen oder quantitativen Nachweis von Antikörpern und zur Bestimmung von deren Avidität
AU2004230606B2 (en) * 2003-04-11 2009-03-19 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Multiple antigenic peptide assay for detection of HIV or SIV type retroviruses
US7432046B2 (en) * 2005-11-02 2008-10-07 Abbott Laboratories Methods for the determination of antibody IgG avidity
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
SMT201800284T1 (it) 2011-06-10 2018-07-17 Univ Oregon Health & Science Glicoproteine cmv e vettori ricombinanti
EP2568289A3 (en) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
CN104330553B (zh) * 2014-11-20 2016-03-09 扬州大学 一种无标记化学发光免疫传感器及其免疫分析方法
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
WO2021022067A2 (en) 2019-07-30 2021-02-04 Kindred Biosciences, Inc. Parvovirus antibodies for veterinary use
EP3961215A1 (de) * 2020-08-25 2022-03-02 Mikrogen GmbH Verfahren zur bestimmung der avidität von gegen coronavirus gerichteten antikörpern sowie hierzu geeignete testkits

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62220865A (ja) * 1986-03-24 1987-09-29 Yatoron:Kk 均一系酵素免疫学的測定方法
WO1990002202A1 (en) * 1988-08-16 1990-03-08 Cetus Corporation Reduction of peroxidatic and catalatic interference with assays of peroxidatic activity
US5512659A (en) 1989-08-04 1996-04-30 Syntex (U.S.A.) Inc. Compositions useful in heterogeneous immunoassays
US5206385A (en) 1992-01-24 1993-04-27 Isp Investments Inc. Urea-hydrogen peroxide-polyvinylpyrrolidone process
US5183901A (en) 1992-01-24 1993-02-02 Isp Investments Inc. Urea-hydrogen peroxide-polyvinylpyrrolidone
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
US5679537A (en) * 1994-10-26 1997-10-21 Mcgill University Immunoassays for measuring the avidity of rheumatoid factor in rheumatoid arthritis
DE69607972T2 (de) * 1995-09-01 2000-08-17 Ortho-Clinical Diagnostics, Inc. Analytisches element und verfahren zur bestimmung eines spezifischen bindenden liganden unter verwendung einer vanadin-bromperoxidase als ein signalgenerierendes enzym

Also Published As

Publication number Publication date
JP3917753B2 (ja) 2007-05-23
EP0875761B1 (de) 2001-03-14
CA2236554C (en) 2008-12-02
DE19718361A1 (de) 1998-11-05
CA2236554A1 (en) 1998-11-02
EP0875761A1 (de) 1998-11-04
DE59800519D1 (de) 2001-04-19
JPH10319016A (ja) 1998-12-04
US6372426B1 (en) 2002-04-16
ATE199783T1 (de) 2001-03-15

Similar Documents

Publication Publication Date Title
DE60335022D1 (de) Internalisierende Antikörper spezifisch für das RAAG10 Zelloberflächenziel
FI84107C (fi) HbA1c:s immunologiska bestaemningsfoerfarande som innefattar denaturering
ATE348843T1 (de) Nachweis von tsh-rezeptor-autoantikörpern mit affinitätsgereinigten antikörpern
BR0111125A (pt) Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos
DE60300339D1 (de) Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben
ATE283289T1 (de) Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten
NO20051345L (no) Humane anti-IFN-gamma noytraliserende antistoffer som selektive IFN-gamma reaksjonsvei inhibitorer
EA030259B8 (ru) Человеческие нейтрализующие антитела к фактору роста нервов (ngf) в качестве селективных ингибиторов метаболического пути ngf
DK96689A (da) Fremgangsmaade til immunbestemmelse og diagnostisk middel til anvendelse ved fremgangsmaaden
ATE460430T1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
RU2005119179A (ru) Способ диагностики заболеваний путем скрининга тканей, крови или эидкостей организма животных или человека [на предмет обнаружения нефизиологических уровней]епцидина и его терапевтическое применение
ES2133772T3 (es) Inmunoensayo para la homocisteina.
NO901899L (no) Hiv-peptider, syntetiske hiv-antigener og immunoanalysekit
MX2024009860A (es) Anticuerpos monoclonales humanos que se dirigen ampliamente a los coronavirus
ATE349533T1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
ATE441114T1 (de) Vorrichtung zum frühen und schnellen immunochromatographischen nachweis von hiv und dessen anwendung
PE20220309A1 (es) Componente de deteccion de antigenos de grupo sanguineo
FI20012603A0 (fi) Diagnostinen menetelmä
ATE420365T1 (de) Präparierung von sphären für diagnostische tests
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
EP1423543A4 (en) IDENTIFICATION OF THE VIRUS OF THE VIRAL RINDER DIARRHOE IN TISSUE SAMPLES
ATE454629T1 (de) Immunoassay zur simultanen immunchemischen bestimmung eines analyten (antigen) und eines gegen den analyten gerichteten therapieantikörpers in proben (recovery immunoassay)
ES2068325T3 (es) Metodo y juego o kit para determinar la actividad funcional de la proteina s en el plasma humano.
DE59903720D1 (de) Rezeptorbindungsassays und reagenziensatz zum nachweis von tsh-rezeptor-autoantikörpern
AR014132A1 (es) Polipeptido que comprende un epitopo de un antigeno del t.cruzi, secuencia aislada de adn, vector de expresion recombinante, celula huesped, metodos parala deteccion de la infeccion por t. cruzi, kit de diagnostico, composicion farmaceutica, vacuna y polipeptido en combinacion

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 875761

Country of ref document: ES